These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8819688)
1. Therapy for acute ischemic stroke: the door opens. Interpreting the NINDS rt-PA stroke study. Sila CA; Furlan AJ Cleve Clin J Med; 1996; 63(2):77-9. PubMed ID: 8819688 [No Abstract] [Full Text] [Related]
2. Thrombolysis in acute ischemic stroke. Luisi A; Hume AL J Am Board Fam Pract; 1998; 11(2):145-51. PubMed ID: 9542706 [TBL] [Abstract][Full Text] [Related]
3. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients. Grotta J N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085 [No Abstract] [Full Text] [Related]
4. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. Caplan LR; Mohr JP; Kistler JP; Koroshetz W N Engl J Med; 1997 Oct; 337(18):1309-10; discussion 1313. PubMed ID: 9345084 [No Abstract] [Full Text] [Related]
10. Hemopericardium and cardiac tamponade after thrombolysis for acute ischemic stroke. Kasner SE; Villar-Cordova CE; Tong D; Grotta JC Neurology; 1998 Jun; 50(6):1857-9. PubMed ID: 9633741 [TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator should not be used in acute ischemic stroke. Riggs JE Arch Neurol; 1996 Dec; 53(12):1306-8. PubMed ID: 8970462 [No Abstract] [Full Text] [Related]
12. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322 [TBL] [Abstract][Full Text] [Related]
13. Hyperacute stroke therapy with tissue plasminogen activator. Alberts MJ Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041 [TBL] [Abstract][Full Text] [Related]
14. t-PA in acute ischemic stroke. Ben Zemenick R Ann Emerg Med; 1998 Jun; 31(6):792-3. PubMed ID: 9624329 [No Abstract] [Full Text] [Related]
15. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Haley EC; Lewandowski C; Tilley BC Ann Emerg Med; 1997 Nov; 30(5):676-82. PubMed ID: 9360581 [No Abstract] [Full Text] [Related]
16. Pathophysiology and mechanisms of acute ischemic stroke. The NINDS rt-PA Stroke Study Group. Bratina P; Rapp K; Barch C; Kongable G; Donnarumma R; Spilker J; Daley S; Braimah J; Sailor S J Neurosci Nurs; 1997 Dec; 29(6):356-60. PubMed ID: 9479656 [TBL] [Abstract][Full Text] [Related]
17. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Steiner T; Bluhmki E; Kaste M; Toni D; Trouillas P; von Kummer R; Hacke W Cerebrovasc Dis; 1998; 8(4):198-203. PubMed ID: 9684058 [TBL] [Abstract][Full Text] [Related]
18. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke; 1997 Nov; 28(11):2109-18. PubMed ID: 9368550 [TBL] [Abstract][Full Text] [Related]
19. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials. Gorelick PB Ann N Y Acad Sci; 2012 Sep; 1268():85-94. PubMed ID: 22994226 [TBL] [Abstract][Full Text] [Related]
20. Cerebral hemorrhage after systemic fibrinolysis in a patient with severe carotid artery stenosis. Stapf C; Mohr JP; Théallier-Jankó A; Mast H Acta Neurol Scand; 1999 Dec; 100(6):407-10. PubMed ID: 10589802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]